Morgan Stanley caused a stir on Tuesday when it put out a "bear case" scenario of $10. Now Citi is getting in on the act.Investingread more
Qualcomm unlawfully suppressed competition in the market for cellphone chips and used its dominant position to impose excessive licensing fees, a U.S. judged ruled.Technologyread more
Target's e-commerce sales also surged 42%, as shoppers increasingly turned to its curbside pickup service for online orders, something Amazon can't offer.Retailread more
Homeowners are taking advantage of lower interest rates, rushing to refinance their mortgages before rates potentially turn higher again.Real Estateread more
Lowe's shares plummeted 8% before the bell Wednesday after the company posted mixed fiscal first-quarter results and cut its forecast for the year, as higher costs weighed on...Retailread more
Department stores are being hung out to dry as Kohl's shares fall after earnings, but some experts still see opportunity in the space.Trading Nationread more
It's not fast and may be years from visiting your neighborhood, but a walking robot is part of Ford's vision for how its autonomous vehicles deliver packages and goods in the...Technologyread more
Brazilian makeup brand Natura Cosmeticos agreed to buy Avon Products, according to two media reports early on Wednesday.Retailread more
Consumers in China are taking to social media to express their support for Huawei as the U.S. government looks to ramp up pressure on the Chinese smartphone maker.Technologyread more
Tensions between the two parties have heightened in recent months as the campaign for seats in the Brussels and Strasbourg-based parliament has crescendoed.Europe Politicsread more
St. Louis Federal Reserve President James Bullard expressed optimism that the United States and China will reach a deal to end their trade war.World Economyread more
New York's Metropolitan Museum of Art announced Wednesday that it would no longer accept gifts from members of the Sackler family, the principal owners of a pharmaceutical company behind the painkiller blamed for fueling the deadly opioid epidemic.
The move comes after other leading cultural institutions, including the Guggenheim in New York and the Tate in London, said they would cut ties with the family amid recent legal scrutiny on Purdue Pharma's production of OxyContin.
"The Sackler family has graciously supported The Met for 50 years and has not proposed any new contributions," Met president and CEO Daniel Weiss said in a statement announcing the decision.
More from NBC News:
Prince Harry wins damages over aerial pictures of his and Meghan Markle's private home
Thousands honor teen who died trying to stop Colorado school shooting
Latina college senior's tribute to immigrant farm worker parents goes viral
"Nonetheless, in consideration of the ongoing litigation, the prudent course of action at this time is to suspend acceptance of gifts from individuals associated with this public health crisis," Weiss added.
The news was first reported by The New York Times.
The Met is one of several cultural centers that have enjoyed the Sacklers' largesse over decades, helping the family earn a reputation as transatlantic patrons of the arts and generous philanthropists. In addition to museums and galleries, members of the sprawling dynasty have also donated to top universities and medical facilities.
Purdue Pharma faces some 1,600 lawsuits that accuse it of promoting OxyContin while downplaying the drug's addictive properties. In March, it settled with the Oklahoma attorney general for $270 million, roughly two months before the scheduled start of a televised trial in the opioid-ravaged state.
Massachusetts last year named eight members of the Sackler family in a complaint that accused the company of spinning a "web of illegal deceit" to boost profits.
Purdue, which has denied the allegations, has generated sales of more than $35 billion since debuting OxyContin in 1995, according to Forbes.